Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (221-230 of 421) with videos related to

Pageof 43
Sort By:
Journal of General Internal Medicine|December 26, 2023
Antibiotic Use in Hospital Urinary Tract Infections After FDA RegulationAaron Brant, Patrick Lewicki, Xian Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2021
Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient ManagementKeith S Kaye, Vikas Gupta, Aruni Mulgirigama, et al.
Infection Control and Hospital Epidemiology|December 6, 2018
It is time to define antimicrobial never eventsJiajun Liu, Keith S Kaye, Nicholas J Mercuro, et al.
Antibiotics (Basel, Switzerland)|January 22, 2024
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii InfectionsRuthy Tal-Jasper, David E Katz, Nadav Amrami, et al.
Clinical Pharmacology and Therapeutics|February 6, 2021
Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection ModelEstefany Garcia, John K Diep, Rajnikant Sharma, et al.
Infectious Diseases and Therapy|July 20, 2020
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 CloneJohn P Mills, Keith S Kaye, Richard Evans, et al.
Infection Control and Hospital Epidemiology|February 20, 2015
Impact of changes in the NHSN catheter-associated urinary tract infection (CAUTI) surveillance criteria on the frequency and epidemiology of CAUTI in intensive care units (ICUs)Anupama Neelakanta, Sarit Sharma, Vishnu Priya Kesani, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Inpatient antibiotic prescribing patterns using the World Health Organization (WHO) Access Watch and Reserve (AWaRe) classification in Okinawa, Japan: A point-prevalence surveyPayal K Patel, Naoyuki Satoh, Masashi Narita, et al.
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Pageof 43

Showing results (221-230 of 421) with videos related to

Sort By:
Pageof 43
Journal of General Internal Medicine|December 26, 2023
Antibiotic Use in Hospital Urinary Tract Infections After FDA RegulationAaron Brant, Patrick Lewicki, Xian Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2021
Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient ManagementKeith S Kaye, Vikas Gupta, Aruni Mulgirigama, et al.
Infection Control and Hospital Epidemiology|December 6, 2018
It is time to define antimicrobial never eventsJiajun Liu, Keith S Kaye, Nicholas J Mercuro, et al.
Antibiotics (Basel, Switzerland)|January 22, 2024
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii InfectionsRuthy Tal-Jasper, David E Katz, Nadav Amrami, et al.
Clinical Pharmacology and Therapeutics|February 6, 2021
Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection ModelEstefany Garcia, John K Diep, Rajnikant Sharma, et al.
Infectious Diseases and Therapy|July 20, 2020
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 CloneJohn P Mills, Keith S Kaye, Richard Evans, et al.
Infection Control and Hospital Epidemiology|February 20, 2015
Impact of changes in the NHSN catheter-associated urinary tract infection (CAUTI) surveillance criteria on the frequency and epidemiology of CAUTI in intensive care units (ICUs)Anupama Neelakanta, Sarit Sharma, Vishnu Priya Kesani, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Inpatient antibiotic prescribing patterns using the World Health Organization (WHO) Access Watch and Reserve (AWaRe) classification in Okinawa, Japan: A point-prevalence surveyPayal K Patel, Naoyuki Satoh, Masashi Narita, et al.
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Pageof 43